| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 143, 65-75, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
A Vakeva, P Laurila and S Meri
Department of Bacteriology and Immunology, University of Helsinki, Finland.
Recent studies have suggested that the complement (C) system is involved in the development of tissue injury of myocardial infarction. As it is not known why the strictly controlled C system starts to react against autologous heart tissue, we have analyzed the expression of various membrane regulators of C (CR1, DAF, MCP, CD59, C8 binding protein) and the pattern of deposition of C components and plasma C regulators (C4b binding protein and vitronectin) in normal (n = 7) and infarcted (n = 13) human myocardium. In the infarcted myocardium deposits of the C membrane attack complex (MAC) were observed by immunofluorescence microscopy, and lesions resembling the transmembrane channels of MAC were detected by transmission electron microscopy. CD59 and C8 binding protein were strongly expressed by muscle cells of normal myocardial tissue. Little or no CR1, MCP, and DAF was observed on these cells. The assembly of MAC was accompanied by the deposition of vitronectin (S-protein) and C4b binding protein in the infarcted areas of myocardium. In accordance with our earlier results the expression of CD59 but not of C8 binding protein was clearly diminished in the lesions. The results show that C8 binding protein, vitronectin, and C4b binding protein do not prevent complement attack against the infarcted myocardium but rather become codeposited with the MAC. Ischemia-induced transformation of nonviable cells into complement activators, acquired loss of resistance to the MAC by shedding of CD59, and recruitment of multifunctional serum proteins by MAC could thus constitute a general process aimed at the clearance of injured tissue.
This article has been cited by other articles:
![]() |
C. Caliezi, W. A. Wuillemin, S. Zeerleder, M. Redondo, B. Eisele, and C. E. Hack C1-Esterase Inhibitor: An Anti-Inflammatory Agent and Its Potential Use in the Treatment of Diseases Other Than Hereditary Angioedema Pharmacol. Rev., March 1, 2000; 52(1): 91 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer Human Heart Generates Complement Proteins That Are Upregulated and Activated After Myocardial Infarction Circ. Res., October 19, 1998; 83(8): 860 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasojima, K. S. Kilgore, R. A. Washington, B. R. Lucchesi, and P. L. McGeer Complement Gene Expression by Rabbit Heart : Upregulation by Ischemia and Reperfusion Circ. Res., June 15, 1998; 82(11): 1224 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Vakeva, A. Agah, S. A. Rollins, L. A. Matis, L. Li, and G. L. Stahl Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion : Role of the Terminal Complement Components and Inhibition by Anti-C5 Therapy Circulation, June 9, 1998; 97(22): 2259 - 2267. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Collard, A. Vakeva, C. Bukusoglu, G. Zund, C. J. Sperati, S. P. Colgan, and G. L. Stahl Reoxygenation of Hypoxic Human Umbilical Vein Endothelial Cells Activates the Classic Complement Pathway Circulation, July 1, 1997; 96(1): 326 - 333. [Abstract] [Full Text] |
||||
![]() |
G. Horstick, A. Heimann, O. Gotze, G. Hafner, O. Berg, P. Boehmer, P. Becker, H. Darius, H.-J. Rupprecht, M. Loos, et al. Intracoronary Application of C1 Esterase Inhibitor Improves Cardiac Function and Reduces Myocardial Necrosis in an Experimental Model of Ischemia and Reperfusion Circulation, February 4, 1997; 95(3): 701 - 708. [Abstract] [Full Text] |
||||
![]() |
G. L. Stahl, W. R. Reenstra, and G. Frendl Complement-Mediated Loss of Endothelium-Dependent Relaxation of Porcine Coronary Arteries : Role of the Terminal Membrane Attack Complex Circ. Res., April 1, 1995; 76(4): 575 - 583. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |